LTR Pharma (ASX:LTP) Beginning Cash Position: A$31.81 Mil (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.57
! 1 Warning Sign
View Full Analysis

What is LTR Pharma Beginning Cash Position?

LTR Pharma ASX:LTP +4.59% 15 Beginning Cash Position is A$31.81 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

LTR Pharma's Beginning Cash Position for the quarter that ended in Dec. 2025 was A$31.81 Mil.

LTR Pharma's quarterly Beginning Cash Position increased from Dec. 2024 (A$3.10 Mil) to Jun. 2025 (A$34.04 Mil) but then declined from Jun. 2025 (A$34.04 Mil) to Dec. 2025 (A$31.81 Mil).

LTR Pharma's annual Beginning Cash Position declined from Jun. 2023 (A$1.91 Mil) to Jun. 2024 (A$1.73 Mil) but then increased from Jun. 2024 (A$1.73 Mil) to Jun. 2025 (A$3.10 Mil).

LTR Pharma Beginning Cash Position Related Terms

LTR Pharma Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Beginning Cash Position Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
0.00 0.15 1.91 1.73 3.10

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial 1.73 5.99 3.10 34.04 31.81
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$31.81 Mil mean?
LTR Pharma (ASX:LTP) has a Beginning Cash Position of A$31.81 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Beginning Cash Position too high?
LTR Pharma's current Beginning Cash Position is A$31.81 Mil. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Beginning Cash Position compare to VRTX and REGN?
LTR Pharma's Beginning Cash Position of A$31.81 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on LTR Pharma and its competitors. LTR Pharma's current Beginning Cash Position is A$31.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Beginning Cash Position of A$31.81 Mil. The current Beginning Cash Position is A$31.81 Mil. LTR Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Beginning Cash Position is A$31.81 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.57
Price